Trailing-twelve-month (TTM) revenue is $4.78 Billion with a year-over-year growth of (7.17%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $1,232,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-22 |
| Q4 FY2025Period ended 2025-12-31 | $1,289,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-04 |
| Q1 FY2026Period ended 2026-03-31 | $1,152,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-22 |
| Q2 FY2026Period ended 2026-06-30 | $1,105,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-22 |
| TTM revenue | $4,778,000,000 |
Current P/S: $6,369,251,611 market capitalization ÷ $4,778,000,000 TTM revenue = 1.33x.
Market capitalization source: FMP quote. Quote observed 2026-09-11T20:00:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $1.10B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-12T00:16:13.304Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Product | $1.4B | $1.3B | $1.6B | $2.0B | $2.1B | $1.9B |
| Service | $2.3B | $2.4B | $2.7B | $3.2B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Eastern Hemisphere | $2.1B | N/A | N/A | N/A | N/A | N/A |
| Europe, Sub-Sahara Africa, Russia | N/A | $737M |
$4.78B
$4.78 Billion
(7.17%)
vs. $5.15B a year ago (TTM)
+7.14%
5 Year compound annual growth rate
1 Year
(7.17%)
3 Year
(0.08%)
5 Year
+7.14%
10 Year
(4.07%)
15 Year
(5.61%)
20 Year
(0.80%)
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $4.92B | ($595.00M) | (10.79%) |
| 2024 | $5.51B | +$378.00M | +7.36% |
| 2023 | $5.13B | +$804.00M | +18.56% |
| 2022 | $4.33B | +$686.00M | +18.82% |
| 2021 | $3.65B | ($40.00M) | (1.09%) |
| 2020 |
TTM Growth
(7.17%)
3-Year CAGR
(0.08%)
5-Year CAGR
+7.14%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-12T00:16:13.304Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $3.4B |
| $3.0B |
| $764M |
| $865M |
| $951M |
| $921M |
| Latin America | N/A | $814M | $1.1B | $1.4B | $1.4B | $898M |
|---|
| Middle East and North Africa | N/A | $1.2B | $1.4B | $1.8B | $2.1B | $2.1B |
|---|
| North America | N/A | $896M | $1.1B | $1.1B | $1.0B | $983M |
|---|
| Western Hemisphere | $1.6B | N/A | N/A | N/A | N/A | N/A |
|---|
| $3.69B |
| ($1.27B) |
| (25.62%) |
| 2019 | $4.95B | ($790.00M) | (13.75%) |
| 2018 | $5.74B | +$45.00M | +0.79% |
| 2017 | $5.70B | ($50.00M) | (0.87%) |
| 2016 | $5.75B | ($3.68B) | (39.05%) |
